Researchers at Tohoku University, working with the University of California, Irvine, report that dopamine dysfunction may be an unrecognized driver of the memory loss seen in Alzheimer's disease. In a mouse model of the disease, dopamine levels in the entorhinal cortex fell to less than 20% of normal - a striking depletion in a brain region that acts as the gateway to the hippocampus and is central to how memories are processed.
The team, led by Kei Igarashi, a Distinguished Professor at Tohoku University School of Medicine, built on earlier work showing that dopamine is required for memory formation in the entorhinal cortex. The depleted animals showed severe deficits in associative memory during odor-based learning tasks, the kind of learning that links a cue to an experience. Electrophysiological recordings backed this up: neurons in the region failed to respond as they should to stimuli that ought to have been encoded as memories.
Why this matters is that decades of Alzheimer's research have centered on the medial temporal lobe without pinning down exactly which neural changes derail memory formation. Framing part of that failure as a chemical signaling problem rather than purely a structural one opens a different therapeutic angle - one aimed at restoring a neurotransmitter system rather than clearing protein deposits.
The findings come from mice, not people, and identifying a mechanism is not the same as demonstrating that correcting it restores memory in patients. Still, the researchers describe dopamine dysfunction as a potential route toward reversing cognitive decline, which makes the entorhinal cortex's dopamine supply a target worth watching in future work.